# Detection of Diffuse Scar in Patients With Diabetes

> **NCT01794091** · PHASE4 · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Eplerenone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01794091
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled in the trial.
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01794091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01794091, "Detection of Diffuse Scar in Patients With Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01794091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*